Recent evidence has demonstrated that activating the cyclic GMP-AMP synthase-stimulator of interferon genes (cGAS-STING) signaling pathway is a powerful strategy for the conversion of immunologically 'cold' tumors to 'hot' ones, leading to a significant augmentation of anti-tumor immunity [18]. The gene discussed is STING1; the disease is neoplasm.